Lubiprostone NDC 43598-168

Product information

Brand name (proprietary)

Lubiprostone

Generic name (nonproprietary)

lubiprostone

Active ingredients

Lubiprostone — 24 ug/1

Dosage form

Capsule, Gelatin coated

Route

Oral

Labeler

Dr. Reddy's Laboratories Inc.

Product type

Prescription drug

Marketing category

NDA authorized genericApplication NDA 021908

Marketing start

Jan 1, 2023

Listing expires

Dec 31, 2027

Other FDA classes

Chloride Channel Activators (Mechanism)

Identifiers

Product ID 43598-168_8f55941d-f7c6-4a16-ae76-c2cd1ab7d607SPL ID 8f55941d-f7c6-4a16-ae76-c2cd1ab7d607SPL set ID 006b8b6c-f0eb-4246-87da-67582984b0e4RxCUI 616578, 794639UNII 7662KG2R6K

Pharmacologic class

Chloride Channel Activator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443598016860 followed by a unit qualifier and the quantity Copy

Package 43598-0168-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under NDA 021908

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 24.